Stuart Rich
Chief Tech/Sci/R&D Officer bei TENAX THERAPEUTICS, INC.
Vermögen: 11 257 $ am 31.03.2024
Profil
Stuart Rich is the founder of PHPrecisionMed, Inc. (founded in 2018) where he held the title of Chief Executive Officer & Director.
He is currently the Chief Medical Officer & Director at Tenax Therapeutics, Inc. (since 2021), the Director-Pulmonary Vascular Disease Program at Bluhm Cardiovascular Institute (since 2015), and a Professor-Medicine at Northwestern University (since 2015).
Dr. Rich previously served as the Chief Medical Officer at United Therapeutics Corp.
(2003-2004), a Professor at the University of Illinois College of Medicine (1980-1996), a Professor-Medicine at Rush Medical College (1996-2004), and a Professor at Pritzker School of Medicine (2004-2015).
He completed his undergraduate degree at the University of Illinois and obtained his doctorate from Stritch School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TENAX THERAPEUTICS, INC.
0,15% | 20.03.2024 | 2 655 ( 0,15% ) | 11 257 $ | 31.03.2024 |
Aktive Positionen von Stuart Rich
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15.01.2021 |
Bluhm Cardiovascular Institute
 Bluhm Cardiovascular Institute Medical/Nursing ServicesHealth Services Bluhm Cardiovascular Institute operates a hospital specializing in cardiology. The private company is based in Chicago. | Corporate Officer/Principal | 01.07.2015 |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | Corporate Officer/Principal | 01.07.2015 |
Ehemalige bekannte Positionen von Stuart Rich
| Unternehmen | Position | Ende |
|---|---|---|
PHPrecisionMed, Inc.
 PHPrecisionMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., PHPrecisionMed, Inc. develops medical drugs. The American company was founded by Stuart Rich. PHPrecisionMed was acquired by Tenax Therapeutics, Inc. on January 19, 2021 for $3.37 million. | Founder | 01.01.2021 |
| Pritzker School of Medicine | Corporate Officer/Principal | 01.07.2015 |
| UNITED THERAPEUTICS CORPORATION | Chief Tech/Sci/R&D Officer | 01.12.2004 |
| Rush Medical College | Corporate Officer/Principal | 01.09.2004 |
| University of Illinois College of Medicine | Corporate Officer/Principal | 01.07.1996 |
Ausbildung von Stuart Rich
| University of Illinois | Undergraduate Degree |
| Stritch School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Bluhm Cardiovascular Institute
Bluhm Cardiovascular Institute Medical/Nursing ServicesHealth Services Bluhm Cardiovascular Institute operates a hospital specializing in cardiology. The private company is based in Chicago. | Health Services |
PHPrecisionMed, Inc.
PHPrecisionMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., PHPrecisionMed, Inc. develops medical drugs. The American company was founded by Stuart Rich. PHPrecisionMed was acquired by Tenax Therapeutics, Inc. on January 19, 2021 for $3.37 million. | Health Technology |
